|Antimicrobial Resistance can kill:
Infections caused by resistant microorganisms often fail to respond to the standard treatment, resulting in prolonged illness, higher health care expenditures with a greater risk of death. It hampers the control of infectious disease: AMR reduces the effectiveness of treatment; thus patients remain infectious for a longer period, increasing the risk of transmitting resistant microorganisms to others.
It increases the costs of health care:
When infections become resistant to first-line drugs, more expensive therapies must be used. A longer duration of illness and treatment, often in hospitals, increases health care costs as well as the economic burden on families and societies.
It jeopardizes health care gains to society:
It has the potential to threaten health security, and damage trade and economies:
The achievements of modern medicine are put at risk by antimicrobial resistance. Without effective antimicrobials for prevention and treatment of infections, the success of organ transplantation, cancer chemotherapy and major surgery would be compromised.
The growth of global trade and travel allows resistant microorganisms to spread rapidly through human contact and food. Estimates show AMR may give rise to losses in Gross Domestic Product of more than 1% and that the indirect costs affecting society may be more than three times the direct health care expenditures, affecting developing economies proportionally more.